Search
Ambrosia psilostachya pollen
go.drugbank.com/drugs/DB10387ApprovedAmbrosia psilostachya pollen is the pollen of the Ambrosia psilostachya plant. Ambrosia psilostachya pollen is mainly used in allergenic testing.
Mixtures: Treatment Set TS333938, Treatment Set TS128872Ambrosia trifida pollen
go.drugbank.com/drugs/DB10386ApprovedAmbrosia trifida pollen is the pollen of the Ambrosia trifida plant. Ambrosia trifida pollen is mainly used in allergenic testing.
Mixtures: Treatment Set TS333938, Treatment Set TS128872Betula populifolia pollen
go.drugbank.com/drugs/DB10724ApprovedBetula populifolia pollen is the pollen of the Betula populifolia plant. Betula populifolia pollen is mainly used in allergenic testing.
Mixtures: Treatment Set TS331657, Treatment Set TS333743Sporisorium cruentum
go.drugbank.com/drugs/DB10873ApprovedSporisorium cruentum is a fungus which can provoke allergic reactions. Sporisorium cruentum extract is used in allergenic testing.
Mixtures: Treatment Set TS128871, Treatment Set TS329906Anas platyrhynchos feather
go.drugbank.com/drugs/DB10421ApprovedAnas platyrhynchos feather is used in allergenic testing.
Mixtures: Treatment Set TS329906, Treatment Set TS332509Ustilago avenae
go.drugbank.com/drugs/DB10704ApprovedUstilago avenae is a fungus which can provoke allergic reactions. Ustilago avenae extract is used in allergenic testing.
Mixtures: Treatment Set TS329906, Treatment Set TS330370Aducanumab
go.drugbank.com/drugs/DB12274ApprovedInvestigationalAducanumab, or BIIB037, is a monoclonal IgG1 antibody that targets extracellular amyloid-β plaques in the brain; similar to gantenerumab, bapineuzumab and solanezumab. Aducanumab is a recombinant antibody derived from patients with slow ...
Tilactase
go.drugbank.com/drugs/DB13761ApprovedInvestigationalIt is produced as a chewable tablet that has to be taken before the consumption of a lactose-containing meal. … [A32591] It is considered by the WHO as part of the International Nonpropietary Names for Pharmaceutical Substances.[L2338]
Brepocitinib
go.drugbank.com/drugs/DB15003ApprovedInvestigational[L64097] It inhibits TYK2- and JAK1-mediated cytokine signaling, blocking phosphorylation of signal transducers and activators of transcription (STATs) that regulate immune cell function. … [L64097] The FDA approved brepocitinib on August 27, 2026 for the treatment of dermatomyositis in adult patients, making it the first targeted oral therapy approved for the condition.[L64115]
Oleic Acid
go.drugbank.com/drugs/DB04224ApprovedInvestigationalVet approvedIt is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent. (Stedman, 26th ed)
Mixtures: Huile D'onagre Vitamin E